Biopharmaceutical giant Amgen has made a significant move by opening a new manufacturing site in central Ohio, solidifying the region’s position as America’s “Silicon Heartland.” The 300,000-square-foot plant near New Albany is set to employ 400 full-time staff and is touted as the company’s most advanced facility to date.
Lt. Governor Jon Husted praised the new facility, hailing it as a prime example of advanced healthcare manufacturing and the importance of a Made-in-America supply chain to support growth and innovation.
Known for its “biology first” approach, Amgen focuses on developing cutting-edge therapeutics to combat serious illnesses like cancer, cardiovascular disease, osteoporosis, asthma, and rheumatoid arthritis.
Amgen Chairman and CEO Robert Bradway expressed the company’s commitment to leveraging its global biomanufacturing network to address pressing health issues worldwide. The company’s products are designed to target diseases with limited treatment options, offering new hope for patients in need.
With a 4 million investment, the state-of-the-art facility will feature cutting-edge technology such as artificial intelligence, automated guided vehicles, and augmented reality for training and remote assistance. This move signifies Amgen’s dedication to pushing the boundaries of innovation and making a meaningful impact in the healthcare industry.
